Marketing-authorisation holder · Germany
Boehringer Ingelheim International GmbH
281 medicines in 6 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
281 medicines in 6 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 281
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTILYSE POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION10 mg · Polvo y disolvente para solución inyectable y para perfusión | Alteplase | Spain | Marketed | 1989 |
| Aptivus | Tipranavir | EU (EMA) | Authorised | 2005 |
| APTIVUSCapsula molle | Tipranavir | Italy | Authorised | |
| Aptivus 100 mg/ml, drankDrank | Tipranavir | Netherlands | Authorised | 2009 |
| APTIVUS 250 MG CAPSULAS BLANDAS250 mg · Cápsula blanda | Tipranavir | Spain | Authorised | 2005 |
| Aptivus 250 mg zachte capsules, zachte capsulesCapsule, zacht | Tipranavir | Netherlands | Authorised | 2005 |
| Berodual Respimat, oplossing voor inhalatie 20 microgram/ 50 microgramInhalatieoplossing | Fenoterol, Ipratropium bromide | Netherlands | Authorised | 2002 |
| GIOTRIFCompressa rivestita con film | Afatinib | Italy | Authorised | |
| Giotrif | Afatinib | EU (EMA) | Authorised | 2013 |
| GIOTRIF 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Afatinib | Spain | Marketed | 2013 |
| Giotrif 20 mg, filmomhulde tablettenFilmomhulde tablet | Afatinib | Netherlands | Authorised | 2013 |
| GIOTRIF 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA30 mg · Comprimido recubierto con película | Afatinib | Spain | Marketed | 2013 |
| Giotrif 30 mg, filmomhulde tablettenFilmomhulde tablet | Afatinib | Netherlands | Authorised | 2013 |
| GIOTRIF 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA40 mg · Comprimido recubierto con película | Afatinib | Spain | Marketed | 2013 |
| Giotrif 40 mg, filmomhulde tablettenFilmomhulde tablet | Afatinib | Netherlands | Authorised | 2013 |
| GIOTRIF 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA50 mg · Comprimido recubierto con película | Afatinib | Spain | Authorised | 2013 |
| Giotrif 50 mg, filmomhulde tablettenFilmomhulde tablet | Afatinib | Netherlands | Authorised | 2013 |
| GLYXAMBICompressa rivestita con film | Empagliflozin, Linagliptin | Italy | Authorised | |
| Glyxambi | Empagliflozin, Linagliptin | EU (EMA) | Authorised | 2016 |
| GLYXAMBI 10 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg + 5 mg · Comprimido recubierto con película | Empagliflozin, Linagliptin | Spain | Marketed | 2017 |
| Glyxambi 10 mg/ 5 mg, filmomhulde tablettenFilmomhulde tablet | Empagliflozin, Linagliptin | Netherlands | Authorised | 2016 |
| GLYXAMBI 25 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA25 mg + 5 mg · Comprimido recubierto con película | Empagliflozin, Linagliptin | Spain | Marketed | 2017 |
| Glyxambi 25 mg/ 5 mg, filmomhulde tablettenFilmomhulde tablet | Empagliflozin, Linagliptin | Netherlands | Authorised | 2016 |
| Jardiance | Empagliflozin | EU (EMA) | Authorised | 2014 |
| JARDIANCECompressa rivestita con film | Empagliflozin | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 127 | 122 | 5 | CompaniesAll medicines |
| Netherlands | 80 | 80 | 0 | CompaniesAll medicines |
| Romania | 27 | 0 | 27 | CompaniesAll medicines |
| European Union (EMA) | 23 | 17 | 6 | CompaniesAll medicines |
| Italy | 23 | 23 | 0 | CompaniesAll medicines |
| Croatia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.